* Rapid Micro Biosystems Inc RPID.OQ reported a quarterly
adjusted loss of 32 cents per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 36 cents per share.
* Revenue rose 21% to $5.04 million from a year ago;
analysts
expected $4.13 million.
* Rapid Micro Biosystems Inc's reported EPS for the quarter
was a
loss of 32 cents.
* The mean earnings estimate of analysts had fallen by
about 15.9%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Rapid Micro Biosystems Inc shares had fallen by 33.5% this
quarter and lost 23.0% so far this year.
* The company reported a quarterly loss of $13.89 million.
* Wall Street's median 12-month price target for Rapid Micro
Biosystems Inc is $5.88
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
5 at 01:32 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.36 -0.32 Beat
Dec. 31 2022 -0.36 -0.39 Missed
Sep. 30 2022 -0.37 -0.38 Missed
Jun. 30 2022 -0.32 -0.31 Beat